5. Helge D. Hartung, MD,a,1 Timothy S. Olson, MD, PhD,b,1 and
Monica Bessler. Acquired Aplastic Anemia in Children Pediatr Clin North
Am.2013, 60: 1311–1336.
6. Scheinberg P, Young NS. How I treat aplastic anemia. Blood.
2011;120(6):1185–96.
7. Rauff B, Idrees M, Shah SA, Butt S, Butt AM, Ali L, Hussain A,
Irshad-Ur-Rehman AM, Ali M. Hepatitis associated aplastic anemia: A
review.2011, Virol J. 28;8:87
8. Zhang J, Yang T, Meta-analysis of association between organo
phosphorus pesticides and aplastic anemia. Zhonghua Liu Xing Bing Xue Za
Zhi.2015, 36(9):1005–9
9. Scheinberg P. Aplastic anemia: therapeutic updates in
immunosuppression and transplantation. Hematology Am Soc Hematol Educ
Program. 2012;292–300
10. Marsh JC, Ball SE, Cavenagh J, Darbyshire P, Dokal I, Gordon-Smith
EC, Keidan J, Laurie A, Martin A, Mercieca J, Killick SB, Stewart R, Yin
JA,( British Committee for Standards in Haematology. Guidelines for the
diagnosis and management of aplastic anaemia. Br J Haematol.
2003,147(1):43–70
11. Gupta V, Eapen M, Brazauskas R, Carreras J, Aljurf M, Gale RP, Hale
GA, Ilhan O, Passweg JR, Ringdén O, Sabloff M, Schrezenmeier H, Socié G,
Marsh JC. Impact of age on outcomes after bone marrow transplantation
for acquired aplastic anemia using HLA-matched sibling donors.
Haematologica.2010, 95(12):2119–25
12. Dezern AE, Brodsky RA. Clinical management of aplastic anemia.
Expert Rev Hematol. 2011,4(2):221–30
13. Scheinberg P, Nunez O, Weinstein B, Scheinberg P, Biancotto A, Wu
CO, Young NS.( 2011 ) Horse versus rabbit antithymocyte globulin in
acquired aplastic anemia. N Engl J Med. 2011,4;365(5):430–8
14. Marsh JC, Mufti GJEltrombopag: a stem cell cookie? Blood.2014,
20;123(12):1774–5. doi: 10.1182/blood-2014-02-553404, PMID 24652959.
15. Al-Ghazaly J, Al-Dubai W, Al-Jahafi AK, Abdullah M, Al-Hashdi A. 1,
waled al-Dubai, A K al-Jahafi, Munasser Abdullah, Adela al-Hashdi.
Cyclosporine monotherapy for severe aplastic anemia: A developing
country experience. Ann Saudi Med. 2005, 25(5):375–9
16. M Mahapatra, P K Singh, M Agarwal, M Prabhu, P Mishra, T Seth, S
Tyagi, H P Patil, R Saxena. Epidemiological clinico-haematological
profile and management of aplastic anaemia. aiimsAiims experience.
JAPI.2015, 63; 30–5
17. Varma N, Malhotra P, Singh S, Sharma DR. Cyclosporine: A monotherapy
in young Indian aplastic anaemia patients. JIMA. arma S.
97(7):292–93(1999).
18. Hanif S, Naz F, Siddiqui E, Raza J. acquired aplastic anaemia,
treatment in a developing country. Pak J. Med Sci. 2007, 23(3):370–74.
19. Garnock-Jones KP, Keam SJ. Eltrombopag. Drugs.2009, 69(5):567–76
20. Qian H, Buza-Vidas N, Hyland CD, Jensen CT, Antonchuk J, Månsson R,
Thoren LA, Ekblom M, Alexander WS, Jacobsen SE. Critical role of
thrombopoietin in maintaining adult quiescent hematopoietic stem cells.
Cell Stem Cell. 2007, (6):671–84
21. Kaushansky K. Historical review: megakaryopoiesis and
thrombopoiesis. Blood. 2008, 1;111(3):981–6. \
22. Alvarado LJ, Andreoni A, Huntsman HD, Cheng H, Knutson JR,
Larochelle A. Heterodimerization of TPO and IFNγ impairs human
hematopoietic stem/progenitor cell signaling and survival in chronic
inflammation [abstract]. Blood 2017, 130:4.
23. Bussel JB, Cheng G, Saleh MN, Psaila B, Kovaleva L, Meddeb B,
Kloczko J, Hassani H, Mayer B, Stone NL, Arning M, Provan D, Jenkins JM.
Eltrombopag for the treatment of chronic idiopathic thrombocyte openic
purpura. N Engl J Med. 29;357(22):2237–47( 2007 ).
24. De Laval B, Pawlikowska P, Petit-Cocault L, Bilhou-Nabera C,
Aubin-Houzelstein G, Souyri M, Pouzoulet F, Gaudry M, Porteu
F.Thrombopoietin-increased DNA-PK-dependent DNA repair limits
hematopoietic stem and progenitor cell mutagenesis in response to DNA
damage. Cell Stem Cell.2013, 3;12(1):37–48
25. Olnes MJ, Scheinberg P, Calvo KR, Desmond R, Tang Y, Dumitriu B,
Parikh AR, Soto S, Biancotto A, Feng X, Lozier J, Wu CO, Young NS,
Dunbar CE. Eltrombopag and improved hematopoiesis in refractory aplastic
anemia. N Engl J Med. 2012, 5;367(1):11–9
26. Desmond R, Townsley DM, Dumitriu B, Olnes MJ, Scheinberg P, Bevans
M, Parikh AR, Broder K, Calvo KR, Wu CO, Young NS, Dunbar CE.
Eltrombopag restores trilineage hematopoiesis in refractory severe
aplastic anemia that can be sustained on discontinuation of drug.
Blood.2014, 20;123(12):1818–25.
27. Townsley DM, Scheinberg P, Winkler T, Desmond R, Dumitriu B, Rios O,
Weinstein B, Valdez J, Lotter J, Feng X, Desierto M, Leuva H, Bevans M,
Wu C, Larochelle A, Calvo KR, Dunbar CE, Young NS. Eltrombopag added to
standard immunosuppression for aplastic anemia. N Engl J Med. 2017,
20;376(16):1540–50.
28. Angelica Barone , Annunziata Lucarelli 2, Daniela Onofrillo 3,
Federico Verzegnassi 4, Sonia Bonanomi 5, Simone Cesaro 6, Francesca
Fioredda 7, Anna Paola Iori , Marrow Failure Study Group of the
Pediatric Haemato-Oncology Italian Association; Diagnosis and management
of acquired aplastic anemia in childhood. Guidelines from the Marrow
Failure Study Group of the Pediatric Haemato-Oncology Italian
Association (AIEOP) Blood Cells Mol Dis. Jun2015, 55(1):40-7
29. Camitta B, Rozman C, Marin P, Nomdedeu B, Montserrat E. Criteria for
severe aplastic anaemia. Lancet.331:303–4 (1988).
30. Lesmana H, Jacobs T, Boals M, Gray N, Lewis S, Ding J, Kang G, Hale
M, Weiss M, Reiss U, Wang W, Wlodarski M. Eltrombopag in children with
severe aplastic anemia Pediatr Blood Cancer.2021, 68(8):e29066.
31. Wire MB, Li X, Zhang J, Sallas W, Aslanis V, Ouatas T Modeling and
simulation support eltrombopag dosing in pediatric patients with immune
thrombocytopenia. Clin Pharmacol Ther.2018, 104(6):1199–207
32. Tichelli A, Schrezenmeier H, Bacigalupo A. Immunosuppressive
treatment of aplastic anemia. In: Schrezenmeier H, Bacigalupo A.
editors. Aplastic anemia: pathophysiology and treatment.
CambridgeUKCambridge UK. Press: Cambridge University Book Company;. p.
154–96 ( 2000).
33. Guinan EC. Clinical aspects of aplastic anemia. Hematol Oncol Clin
North Am.;11(6):1025–44( 1997).
34. Mackenzie IL, Manoharan A. Cyclosporine A inthein the treatment of
aplastic anemia. Am J Hematol 1988,28(3):211(1988) .
35. Tötterman TH, Höglund M, Bengtsson M, Simonsson B, Almqvist D,
Killander A.Treatment of pure red cell aplasia and aplastic anemia with
cyclosporine. Long term clinical effects. Eur J Haematol.1989,
42(2):126–33
36. Leonard EM, Raefsky E, Griffith P, Kimball J, Nienhuis AW, Young NS.
Cyclosporin therapy of aplastic anemia, congenital and acquired red cell
aplasia. Br J Haematol.1989;72(2):278–84
37. M Hinterberger-Fischer 1, P Höcker, K Lechner, H Seewann, W
Hinterberger. Oral cyclosporin-A is effective treatment foruntreatedfor
untreated and also for previously immunosuppressed patients with severe
bone marrow failure. Eur J Haematol 1989;43:136–42.
38. Maschan A, Bogatcheva N, Kryjanovskii O, Shneider M, Litvinov D,
Mitiushkina T, Timakov A, Timakova M, Samotchatova E, Rumiantsev A.
Results at a single centre of immunosuppression with cyclosporine-A in
66 children with aplastic anaemia. Br J Haematol.1999, 106(4):967–70.
39. Shetty M, Narendra AM, Adiraju KP, Modugu NR. Study of Aplastic
Anaemia with Cyclosporine in Resource Poor Setting. J Clin Diagn
Res.2016, 10(6):OC15–8.
40. Fang M, Hua Song H, Zhang J, Li S, Shen D, Tang. Efficacy and safety
of immunosuppressive therapy with or without eltrombopag in pediatric
patients with acquired aplastic anemia: A Chinese retrospective study.
Pediatr Pediatr Hematol Oncol 2021;38(7):633-646
41. Jie M, Fu L, Li S, He Y, Yao J, Cheng X, Zhang L, Zheng J, Zhang R,
Wu R . Efficacy and safety of eltrombopag in the first-line therapy of
severe aplastic anemia in children. Pediatr Hematol
Oncol.2021,38(7):647–57(2021). .
42. Scheinberg P, Maier J, Arikan OO, Finelli C, Jang J Eltrombopag and
Cyclosporine as First-Line Therapy in Patients with Severe Acquired
Aplastic Anemia: A Two-part, 5-year, Single-Arm, Multicenter,
Open-label, Phase 2 Trial (SOAR. Clinical lymphoma, myeloma &
leukemia.2017, Volume 17, supplement 2, s389-s390,07.242
43. Yu-Yan Hwang 1, Harinder Gill 1, Thomas S Y Chan 1, Garret M K Leung
1, Carol Y M Cheung 1, Yok-Lam Kwong Eltrombopag in the management of
aplastic anaemia: real-world experience in a non-trial setting
Hematology.2018, 23(7):399-404
44. Bingyi Wu , Jiahui Cai, Li Yingshi, Dong Ruihong. Eltrombopag
Combined with G-CSF and Cyclosporine Could Effect for Severe Acquired
Aplastic Anemia, Blood,2018, 132.